Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 19/20 | 0.57 |
| ▸ | KDR | P35968 | 2/20 | 0.53 |
| ▸ | FBP1 | P09467 | 2/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.50 |
| ▸ | AURKA | O14965 | 1/20 | 0.50 |
| ▸ | INSR | P06213 | 1/20 | 0.50 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.50 |
| ▸ | FLT4 | P35916 | 1/20 | 0.50 |
| ▸ | CLK1 | P49759 | 1/20 | 0.50 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.50 |
| ▸ | TEK | Q02763 | 1/20 | 0.50 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6991313 | 0.96 | EGFR (0.57) | EGFRKDRFBP1ERBB2AURKA | |
| SCHEMBL1383950 | 0.91 | EGFR (0.70) | EGFRKDRFBP1ERBB2AURKA | |
| SCHEMBL1384673 | 0.91 | EGFR (0.70) | EGFRKDRFBP1ERBB2AURKA | |
| SCHEMBL6989473 | 0.89 | EGFR (0.58) | EGFRKDRFBP1ERBB2EPHB4 | |
| SCHEMBL7688337 | 0.88 | EGFR (0.54) | EGFRKDRFBP1 | |
| SCHEMBL4225530 | 0.88 | EGFR (0.57) | EGFRKDRFBP1ERBB2EPHB4 | |
| SCHEMBL4226627 | 0.88 | EGFR (0.57) | EGFRKDRFBP1ERBB2EPHB4 | |
| SCHEMBL4220580 | 0.88 | EGFR (0.57) | EGFRKDRFBP1ERBB2EPHB4 | |
| SCHEMBL1386754 | 0.88 | EGFR (0.57) | EGFRKDRFBP1ERBB2EPHB4 | |
| SCHEMBL6988452 | 0.85 | EGFR (0.66) | EGFRKDRERBB2PDGFRBEPHB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1322645-A2 | QUINAZOLINES, MEDICAMENTS, WHICH CONTAIN THESE COMPOUNDS AND WHICH ARE EFFECTIVE AS TYROSINE KINASE INHIBITORS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF | Boehringer Ingelheim Pharma GmbH & Co.KG (DE) | 2003-07-02 | — | — | EP | disclosed |
| US-6403580-B1 | HAVING AN INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES, THE USE THEREOF FOR TREATING DISEASES, PARTICULARLY TUMORAL DISEASES, DISEASES OF THE LUNGS AND RESPIRATORY TRACT, AND THE PREPARATION THEREOF. | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-06-11 | — | — | US | disclosed |
| WO-2002018375-A1 | QUINAZOLINES, MEDICAMENTS, WHICH CONTAIN THESE COMPOUNDS AND WHICH ARE EFFECTIVE AS TYROSINE KINASE INHIBITORS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-03-07 | — | — | WO | disclosed |